Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
British National Formulary, no. 33. London: British Medical Assodation and the Royal Pharmaceutical Society of Great Britain, 1997.
Gittinger JW, Asdourian GK . Papillopathy caused by amiodarone. Arch Ophthalmol 1987;105:349–51.
Chew E, Ghosh M, McCulloch C . Amiodarone-induced cornea verticillata. Can J Ophthalmol 1982;17:96–9.
Nazarian SM, Jay WM . Bilateral optic neuropathy associated with amiodarone therapy. Clin Neuro-ophthalmol 1988;8:25–8.
Mansour AM, Pulkin JE, O'Grady R . Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol 1988;8:231–7.
Duff GR, Fraser AG . Impairment of colour vision associated with amiodarone keratopathy. Acta Ophthalmol (Copenh) 1987;65:48–52.
Sedwick LA . Getting to the heart of visual loss: when cardiac medicine may be dangerous to the optic nerves. Surv Ophthalmol 1992;36:366–72.
Feiner LA, Younge BR, Kazmier FJ, Stricker BH, Fraunfelder FT . Optic neuropathy and amiodarone therapy. Mayo Clin Proc 1987;62:702–17.
Kreig P, Schipper I . Bilateral Optikusneuropathie nach Amiodarone-therapie. (Bilateral optic neuropathy following amiodarone therapy.) Klin Monatsbl Augenheilkd 1992;200:128–32.
Gittinger JW, Asdourian GK . Amiodarone-related optic neuropathy [letter]. Mayo Clin Proc 1988;62:210.
Younge BR . Amiodarone optic neuropathy. J Clin Neuroophthalmol 1988;8:29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seemongal-Dass, R., Spencer, S. Bilateral optic neuropathy linked with amiodarone. Eye 12, 474–477 (1998). https://doi.org/10.1038/eye.1998.108
Issue date:
DOI: https://doi.org/10.1038/eye.1998.108
